Try our Advanced Search for more refined results

HIP HEALTH PLAN OF F, et al v. SCHERING-PLOUGH, et al

  1. October 06, 2017

    $60M Merck Pay-For-Delay Deal, $20M Atty Fees Approved

    A New Jersey federal judge Thursday signed off on a $60 million settlement reached by Merck and Upsher-Smith with a class of direct purchasers who accuse the drug companies of engaging in a pay-for-delay scheme tied to potassium supplements and then granted more than $20 million in attorneys' fees to the class counsel.

  2. July 18, 2017

    Class Attys Seek $20M In Fees In Merck Pay-For-Delay MDL

    Attorneys representing direct purchasers of potassium supplements on Monday asked for a third of the $60.2 million settlement ending claims Merck & Co. Inc. and Upsher-Smith Laboratories Inc. engaged in a pay-for-delay scheme, saying a $20 million share was fair compensation after more than 16 years of litigating the landmark case.

  3. May 23, 2017

    Judge Greenlights Merck's $60M Deal In Pay-For-Delay MDL

    A New Jersey federal judge on Tuesday gave his preliminary approval to a $60.2 million settlement among Merck & Co. Inc., Upsher-Smith Laboratories Inc. and direct purchasers of the potassium supplement K-Dur, which will end long-running multidistrict litigation accusing the drug companies of engaging in a pay-for-delay scheme.

  4. May 16, 2017

    Merck Seeks OK For $60M Settlement In Pay-For-Delay Row

    Merck & Co. Inc. and Upsher-Smith Laboratories Inc. have agreed to pay $60.2 million to resolve long-running multidistrict litigation accusing them of a pay-for-delay scheme for the potassium supplement K-Dur, according to a motion Monday asking a New Jersey federal judge to bless the settlement.

  5. February 17, 2017

    Merck Settles Long-Running Pay-For-Delay Suit

    Merck & Co. Inc. and Upsher-Smith Laboratories Inc. have told a New Jersey federal court they have settled their long-running MDL accusing them of pay-for-delay over the potassium supplement K-Dur.

  6. January 18, 2017

    Merck Says K-Dur Buyers Can't Save Pay-For-Delay Suit

    Merck & Co. Inc. and Upsher-Smith Laboratories Inc. have asked a New Jersey federal court to deal them a quick win in long-running pay-for-delay litigation over potassium supplement K-Dur, saying direct purchasers of the medication can't prove the drug was a market unto itself and that they were wrongly edged out of that market.

  7. February 25, 2016

    Merck Gets K-Dur Pay-For-Delay Antitrust Case Narrowed

    A New Jersey federal judge on Thursday narrowed the antitrust claims that Merck & Co. Inc. faces in a long-running pay-for-delay litigation over potassium supplement K-Dur, eliminating one of the two settlement deals it cut with generics makers from the case.

  8. April 09, 2015

    Merck Fights Bid To Strike Replies In K-Dur Pay-For-Delay Suit

    Merck & Co. Inc. has asked a New Jersey federal judge to deny a bid to strike part of its summary judgment reply brief in the long-running pay-for-delay litigation over potassium supplement K-Dur, saying the company's direct responses to arguments made by plaintiffs in their opposition brief were appropriate.